Welcome to
Издательство Атмосфера

· Журналы
· Книги
· О проекте

·Электронные версии книг издательства “Атмосфера” поступили в продажу

Издательство “Атмосфера” идет в ногу со временем и открывает на своем сайте раздел электронных версий своих книг. Теперь вы можете приобрести не только традиционную бумажную книгу в картонном переплете, но и .pdf-файл, снабженный гиперссылками на каждую главу издания. В электронной версии проще отыскать рисунок и таблицу. Чтобы обратиться к ним, достаточно нажать на ссылку на каждый из них. Исчезла зависимость от тиража – вы можете приобрести даже те бестселлеры, тираж которых уже разошелся, такие как “Саркоидоз” или “Заболевания органов дыхания при беременности”. Упростилось получение вами книг – в течение двух рабочих дней после оплаты требуемые файлы придут на ваш e-mail. Ну и наконец, цена – электронные версии наших книг гораздо дешевле, чем бумажные издания. Заказывайте электронные версии книг издательства “Атмосфера” на сайте, а также по телефону: (495) 730-63-51 и по e-mail: atm-press2012@yandex.ru


ИНТЕРНЕТ-МАГАЗИН
Издательство Атмосфера


Телефон издательства

  
Нервные болезни
2022 / N 1

Сывороточные биомаркеры при повреждении головного мозга
Н.Р. Мухамадеева, О.В. Качемаева, И.В. Бузаев, Р.М. Галимова, И.И. Юсупова, Ш.З. Загидуллин, Н.Ш. Загидуллин

References

1. Califf RM. Biomarker definitions and their applications. Experimental Biology and Medicine (Maywood, N.J.) 2018 Feb;243(3):213-21.
2. Garg P, Morris P, Fazlanie A L, Vijayan S, Dancso B, Dastidar AG, Plein S, Mueller C, Haaf P. Cardiac biomarkers of acute coronary syndrome: from history to high-sensitivity cardiac troponin. Internal and Emergency Medicine 2017 Mar;12(2):147-55.
3. Scheitz JF, Stengl H, Nolte CH, Landmesser U, Endres M. Neurological update: use of cardiac troponin in patients with stroke. Journal of Neurology 2021 Jun;268(6):2284-92.
4. Zagidullin N, Motloch LJ, Gareeva D, Hamitova A, Lakman I, Krioni I, Popov D, Zulkarneev R, Paar V, Kopp K, Jirak P, Ishmetov V, Hoppe UC, Tulbaev E, Pavlov V. Combining novel biomarkers for risk stratification of two-year cardiovascular mortality in patients with ST-elevation myocardial infarction. Journal of Clinical Medicine 2020 Feb;9(2):550.
5. Bustamante A, López-Cancio E, Pich S, Penalba A, Giralt D, García-Berrocoso T, Ferrer-Costa C, Teresa Gasull T, Hernández-Pérez M, Millan M, Rubiera M, Cardona P, Cano L, Quesada H, Terceño M, Silva Y, Castellanos M, Garces M, Reverté S, Ustrell X, Marés R, Baiges JJ, Serena J, Rubio F, Salas E, Dávalos A, Montaner J. Blood biomarkers for the early diagnosis of stroke: the stroke-chip study. Stroke 2017 Sep;48(9):2419-25.
6. Harpaz D, Seet RCS, Marks RS, Tok AIY. Blood-based biomarkers are associated with different ischemic stroke mechanisms and enable rapid classification between cardioembolic and atherosclerosis etiologies. Diagnostics (Basel) 2020 Oct;10(10):804.
7. Endocrinology of the heart in health and disease. Schisler JC, Lang CH, Willis MS, editors. Cambridge: Academic Press; 2017: 3-39.
8. Fonseca AC, Coelho P. Update on biomarkers associated to cardioembolic stroke: a narrative review. Life (Basel, Switzerland) 2021 May;11(5):448.
9. Di Castelnuovo A, Veronesi G, Costanzo S, Zeller T, Schnabel RB, de Curtis A, Salomaa V, Borchini R, Ferrario M, GiampaoliS, Kee F, Söderberg S, Niiranen T, Kuulasmaa K, Giovanni de Gaetano G, Donati MB, Blankenberg S, Iacoviello L; BiomarCaRE Investigators. NT-proBNP (N-Terminal pro-B-type natriuretic peptide) and the risk of stroke. Stroke 2019 Mar;50(3):610-7.
10. Rodríguez-Castro E, Hervella P, López-Dequidt I, Arias-Rivas S, Santamaría-Cadavid M, López-Loureiro I, da Silva-Candal A, Pérez-Mato M, Sobrino T, Campos F, Castillo J, Rodríguez-Yáñez M, Iglesias-Rey R. NT-pro-BNP: a novel predictor of stroke risk after transient ischemic attack. International Journal of Cardiology 2020;298:93-7.
11. Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy. Circulation 2012 Apr 3;125(13):1605-16.
12. Bai J, Sun H, Xie L, Zhu Y, Feng Y. Detection of cardioembolic stroke with B-type natriuretic peptide or N-terminal pro-BNP: a comparative diagnostic meta-analysis. International Journal of Neuroscience 2018 Nov;128(11):1100-8.
13. Pathak A, Pandey SP, Madhukar P, Dev P, Joshi D, Mishra VN, Chaurasia RN. Blood biomarkers for the differentiation of cardiac ischemic stroke subtypes: a systematic review. Cardiovascular & Hematological Disorders – Drug Targets 2019;19(3):215-27.
14. Kneihsl M, Gattringer T, Bisping E, Scherr D, Raggam R, Mangge H, Enzinger C, Fandler-Höfler S, Eppinger S, Hermetter C, Bucnik B, Poltrum B, Niederkorn K, Fazekas F. Blood biomarkers of heart failure and hypercoagulation to identify atrial fibrillation-related stroke. Stroke 2019 Aug;50(8):2223-6.
15. Sternberg M, Pasini E, Chen-Scarabelli C, Corsetti G, Patel H, Linardi D, Onorati F, Faggian G, Scarabelli T, Saravolatz L. Elevated cardiac troponin in clinical scenarios beyond obstructive coronary artery disease. Medical Science Monitor 2019 Sep;25:7115-25.
16. Zhang L, Wang Z, Qi S. Cardiac troponin elevation and outcome after subarachnoid hemorrhage: a systematic review and meta-analysis. Journal of Stroke Cerebrovascular Diseases 2015 Oct;24(10):2375-84.
17. Scheitz JF, Nolte CH, Doehner W, Hachinski V, Endres M Stroke-heart syndrome: clinical presentation and underlying mechanisms. The Lancet. Neurology 2018;17(12):1109-20.
18. Scheitz JF, Mochmann HC, Erdur H, Tutuncu S, Haeusler KG, Grittner U, Laufs U, Endres M, Nolte CH. Prognostic relevance of cardiac troponin T levels and their dynamic changes measured with a high-sensitivity assay in acute ischaemic stroke: analyses from the TRELAS cohort. International Journal of Cardiology 2014 Dec;177(3):886-93.
19. Wrigley P, Khoury J, Eckerle B, Alwell K, Moomaw CJ, Woo D, Flaherty ML, La Rosa F, Mackey J, Adeoye O, Martini S, Ferioli S, Kissela BM, Kleindorfer DO. Prevalence of positive troponin and echocardiogram findings and association with mortality in acute ischemic stroke. Stroke 2017 May;48(5):1226-32.
20. Broersen LHA, Stengl H, Nolte CH, Westermann D, Endres M, Siegerink B, Scheitz JF. Association between high-sensitivity cardiac troponin and risk of stroke in 96 702 individuals: a meta-analysis. Stroke 2020 Apr;51(4):1085-93.
21. Scheitz JF, Pare G, Pearce LA, Mundl H, Peacock WF, Czlonkowska A, Sharma M, Nolte CH, Shoamanesh A, Berkowitz SD, Krahn T, Endres M; NAVIGATE-ESUS Biomarker Working Group. High-sensitivity cardiac troponin T for risk stratification in patients with embolic stroke of undetermined source. Stroke 2020 Aug;51(8):2386-94.
22. von Rennenberg R, Siegerink B, Ganeshan R, Villringer K, Doehner W, Audebert HJ, Endres M, Nolte CH, Scheitz JF. High-sensitivity cardiac troponin T and severity of cerebral white matter lesions in patients with acute ischemic stroke. Journal of Neurology 2019 Jan;266(1):37-45.
23. Broersen LHA, Siegerink B, Sperber PS, von Rennenberg R, Piper SK, Nolte CH, Heuschmann PU, Endres M, Scheitz JF, Liman TG. High-sensitivity cardiac troponin T and cognitive function in patients with ischemic stroke. Stroke 2020 May;51(5):1604-7.
24. Krishnamoorthy V, Mackensen GB, Gibbons EF, Vavilala MS. Cardiac dysfunction after neurologic injury: what do we know and where are we going? Chest 2016 May;149(5):1325-31.
25. Wang L, Deng L, Yuan R, Liu J, Li Y, Liu M. Association of matrix metalloproteinase 9 and cellular fibronectin and outcome in acute ischemic stroke: a systematic review and meta-analysis. Frontiers in Neurology 2020 Nov;11:523506.
26. Elkind MSV, Tai W, Coates K, Paik MC, Sacco RL. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke. Archives of Internal Medicine 2006 Oct 23;166(19):2073-80.
27. Mallat Z, Lambeau G, Tedgui A. Lipoprotein-associated and secreted phospholipases A2 in cardiovascular disease: roles as biological effectors and biomarkers. Circulation 2010;122(21):2183-200.
28. Cao J, Yan P, Zhou Y, Zhou X, Sun Z, Zhu XQ. Clinical utility of the serum level of lipoprotein-related phospholipase A2 in acute ischemic stroke with cerebral artery stenosis. Frontiers in Neurology 2021 Mar;12:642483.
29. Weitz JI, Fredenburgh JC, Eikelboom JW. A test in context: D-dimer. Journal of the American College of Cardiology 2017 Nov;70(19):2411-20.
30. Ferro JM, Bousser MG, Canhão P, Coutinho JM, Crassard I, Dentali F, di Minno M, Maino A, Martinelli I, Masuhr F, de Sousa DA, Stam J; European Stroke Organization. European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis – endorsed by the European Academy of Neurology. European Stroke Journal 2017 Sep;2(3):195-221.
31. Zhang J, Song Y, Shan B, He M, Ren Q, Zeng Y, Liu Z, Liu H, Xu J. Elevated level of D-dimer increases the risk of stroke. Oncotarget 2017 Dec;9(2):2208-19.
32. Folsom AR, Gottesman RF, Appiah D, Shahar E, Mosley TH. Plasma D-dimer and incident ischemic stroke and coronary heart disease: the atherosclerosis risk in communities study. Stroke 2016 Jan;47(1):18-23.
33. Shen Y, Li Y, Chen C, Wang W, Li T. D-dimer and diffusion-weighted imaging pattern as two diagnostic indicators for cancer-related stroke. Medicine 2020 Jan;99(4):e18779.
34. Xie X, Chen L, Zeng J, Qin C, Cheng D, Wei X, Liang Z. Clinical features and biological markers of lung cancer-associated stroke. The Journal of International Medical Research 2016 Dec;44(6):1483-91.
35. Dardiotis E, Aloizou AM, Markoula S, Siokas V, Tsarouhas K, Tzanakakis G, Libra M, Kyritsis A, Brotis AG, Aschner M, Gozes I, Bogdanos DP, Spandidos DA, Mitsias PD, Tsatsakis A. Cancer-associated stroke: pathophysiology, detection and management (Review). International Journal of Oncology 2019 Mar;54(3):779-96.
36. Wang JY, Zhang GJ, Zhuo SX, Wang K, Hu XP, Zhang H, Qu LD. D-dimer > 2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Neurological Research 2018 Nov;40(11):948-54.
37. Meng Z, Zhao Y, He Y. Fibrinogen level predicts outcomes in critically ill patients with acute exacerbation of chronic heart failure. Disease Markers 2021 Apr;2021:6639393.
38. Wang J, Tan GJ, Han LN, Bai YY, He M, Liu HB. Novel biomarkers for cardiovascular risk prediction. Journal of Geriatric Cardiology 2017 Feb;14(2):135-50.
39. Woodward M, Lowe GDO, Campbell DJ, Colman S, Rumley A, Chalmers J, Neal BC, Patel A, Jenkins AE, Kemp BE, MacMahon SW. Associations of inflammatory and hemostatic variables with the risk of recurrent stroke. Stroke 2005 Oct;36(10):2143-7.
40. Whiteley W, Jackson C, Lewis S, Lowe G, Rumley A, Sandercock P, Wardlaw J, Dennis M, Sudlow C. Association of circulating inflammatory markers with recurrent vascular events after stroke: a prospective cohort study. Stroke 2011 Jan;42(1):10-6.
41. Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR; NINDS rtPA Stroke Study Group. Hemostatic activation and outcome after recom¬binant tissue plasminogen activator therapy for acute ischemic stroke. Stroke 2006 Jul;37(7):1798-804.
42. Trouillas P, Derex L, Philippeau F, Nighoghossian N, Honnorat J, Hanss M, Ffrench P, Adeleine P, Dechavanne M. Early fibrinogen degradation coagulopathy is predictive of parenchymal hematomas in cerebral rt-PA thrombolysis: a study of 157 cases. Stroke 2004 Jun;35(6):1323-8.
43. Cocho D, Borrell M, Martí-Fàbregas J, Montaner J, Castellanos M, Bravo Y, Molina-Porcel L, Belvís R, Díaz-Manera JA, Martínez-Domeño A, Martínez-Lage M, Millán M, Fontcuberta J, Martí-Vilalta JL. Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator. Stroke 2006 Apr;37(4):996-9.
44. Matosevic B, Knoflach M, Werner P, Pechlaner R, Zangerle A, Ruecker M, Kirchmayr M, Willeit J, Kiechl S. Fibrinogen degradation coagulopathy and bleeding complications after stroke thrombolysis. Neurology 2013 Mar 26;80(13):1216-24.
45. Castro AR, Silva SO, Soares SC. The use of high sensitivity C-reactive protein in cardiovascular disease detection. Journal of Pharmacy & Pharmaceutical Sciences 2018;21(1):496-503.
46. Yang X, Zhang D, Zhao Y, Quanman Li, Guo C, Tian G, Han M, Qie R, Huang S, Zhou Q, Zhao Y, Feng Y, Wu X, Zhang Y, Li Y, Wu Y, Cheng C, Hu D, Sun L. Association between serum level of C-reactive protein and risk of cardiovascular events based on cohort studies. Journal of Human Hypertension 2021 Dec;35(12):1149-58.
47. Arroyo-Espliguero R, Viana-Llamas MC, Silva-Obregón A, Avanzas P. The role of C-reactive protein in patient risk stratification and treatment. European Cardiology 2021 Jul;16:e28.
48. Chapman N, Huxley R, Anderson C, Bousser MG, Chalmers J, Colman S, Davis S, Donnan G, MacMahon S, Neal B, Warlow C, Woodward M. Effects of a perindopril-based blood pressure-lowering regimen on the risk of recurrent stroke according to stroke subtype and medical history. The PROGRESS Trial. Stroke 2004;35:116-21.
49. Elkind MSV, Luna JM, McClure LA, Zhang Y, Coffey CS, Roldan A, Del Brutto OH, Pretell EJ, Pettigrew LC, Meyer BC, Tapia J, White C, Benavente OR; LIMITS Investigators. C-reactive protein as a prognostic marker after lacunar stroke: the levels of inflammatory markers in the treatment of stroke (LIMITS) study. Stroke 2014 Mar;45(3):707-16.
50. Furuhashi M, Saitoh S, Shimamoto K, Miura T. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clinical Medicine Insights. Cardiology 2015 Feb;8(Suppl 3):23-33
51. Montellano FA, Ungethüm K, Ramiro L, Nacu A, Hellwig S, Fluri F, Whiteley WN, Bustamante A, Montaner J, Heuschmann PU. Role of blood-based biomarkers in ischemic stroke prognosis: a systematic review. Stroke 2021 Jan;52(2):543-51.
52. Turner MW. The role of mannose-binding lectin in health and disease. Molecular Immunology 2003 Nov;40(7):423-9.
53. Fumagalli S, De Simoni MG. Lectin complement pathway and its bloody interactions in brain ischemia. Stroke 2016 Dec;47(12):3067-73.
54. Hamade B, Huang DT. Procalcitonin: where are we now? Critical Care Clinics 2020 Jan;36(1):23-40.
55. Săcărescu A, Turliuc MD, Brănișteanu DD. Role of copeptin in the diagnosis of traumatic neuroendocrine dysfunction. Neuropeptides 2021 Oct;89:102167.
56. Greisenegger S, Segal HC, Burgess AI, Poole DL, Mehta Z, Rothwell PM. Copeptin and long-term risk of recurrent vascular events after transient ischemic attack and ischemic stroke: population-based study. Stroke 2015 Nov;46(11):3117-23.
57. Katan M, Nigro N, Fluri F, Schuetz P, Morgenthaler NG, Jax F, Meckel S, Gass A, Bingisser R, Steck A, Kappos L, Engelter S, Müller B, Christ-Crain M. Stress hormones predict cerebrovascular re-events after transient ischemic attacks. Neurology 2011;76(6):563-6.
58. De Marchis GM, Katan M, Weck A, Fluri F, Foerch C, Findling O, Schuetz P, Buhl D, El-Koussy M, Gensicke H, Seiler M, Morgenthaler N, Mattle HP, Mueller B, Christ-Crain M, Arnold M. Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study. Neurology 2013 Apr;80(14):1278-86.
59. De Marchis GM, Dankowski T, König IR, Fladt J, Fluri F, Gensicke H, Foerch C, Findling O, Kurmann R, Fischer U, Luft A, Buhl F, Engelter ST, Lyrer PA, Christ-Crain M, Arnold M, Katan M. A novel biomarker-based prognostic score in acute ischemic stroke: the CoRisk score. Neurology 2019 Mar;92(13):e1517-25.
60. Lee DY, Kim E, Choi MH. Technical and clinical aspects of cortisol as a biochemical marker of chronic stress. BMB Reports 2015 Apr;48(4):209-16.
61. Perry LA, Lucarelli T, Penny-Dimri JC, McInnes MD, Mondello S, Bustamante A, Montaner J, Foerch C, Kwan P, Davis S, Yan B. Glial fibrillary acidic protein for the early diagnosis of intracerebral hemorrhage: systematic review and meta-analysis of diagnostic test accuracy. International Journal of Stroke 2019 Jun;14(4):390-9.
62. Liu Z, Yang C, Wang X, Xiang Y. Blood-based biomarkers: a forgotten friend of hyperacute ischemic stroke. Frontiers in Neurology 2021 Jul;12:634717.
63. Dagonnier M, Donnan GA, Davis SM, Dewey HM, Howells DW. Acute stroke biomarkers: are we there yet? Frontiers in Neurology 2021 Feb;12:619721.
64. Wang C, Wang L, Deng L, Qiu S, Zhang S, Liu M, Wu B. Association between mean platelet volume and hemorrhagic transformation in acute ischemic stroke patients. Current Neurovascular Research 2020;17(1):3-10.
65. Park DW, Park SH, Hwang SK. Serial measurement of S100B and NSE in pediatric traumatic brain injury. Child’s Nervous System 2019 Feb;35(2):343-8.
66. Steliga A, Kowiański P, Czuba E, Waśkow M, Moryś J, Lietzau G. Neurovascular unit as a source of ischemic stroke biomarkers-limitations of experimental studies and perspectives for clinical application. Translational Stroke Research 2020 Aug;11(4):553-79.
67. Hu Y, Meng R, Zhang X, Guo L, Li S, Wu Y, Duan J, Ding Y, Ji X. Serum neuron specific enolase may be a marker to predict the severity and outcome of cerebral venous thrombosis. Journal of Neurology 2018 Jan;265(1):46-51.
68. Stammet P. Blood biomarkers of hypoxic-ischemic brain injury after cardiac arrest. Seminars in Neurology 2017 Feb;37(1):75-80.
69. Iłżecki M, Iłżecka J, Przywara S, Terlecki P, Grabarska A, Stepulak A, Zubilewicz T. Serum neuron-specific enolase as a marker of brain ischemia-reperfusion injury in patients undergoing carotid endarterectomy. Acta Clinica Croatica 2016 Dec;55(4):579-84.
70. Duda I, Wiórek A, Krzych ŁJ. Biomarkers facilitate the assessment of prognosis in critically ill patients with primary brain injury: a cohort study. International Journal of Environmental Research and Public Health 2020 Jun;17(12):4458.
71. Ingebrigtsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentrations of protein S-100 after minor head injury: a biochemical serum marker with prognostic value? Journal of Neurology, Neurosurgery and Psychiatry 1995 Jul;59(1):103-4.
72. Galimova RM, Illarioshkin SN, Buzayev IV, Kachemayeva OV. Therapy of motor disorders by focused ultrasound under control of magnetic resonance imaging. Recommendations for neurologists on the selection of patients. Bulletin of the National Society for the Study of Parkinson’s Disease and Movement Disorders 2020;1:9-15 (In Russian).
  

[ Содержание выпуска N 1 | Выпуски журнала | Список журналов ]